Zhengye Biotechnology Holding Limited Class A Company Profile
NASDAQ: ZYBTHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.19 +3.49%
Zhengye Biotechnology at a glance
Zhengye Biotechnology Holding Limited Class A (NASDAQ: ZYBT) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector headquartered in Jilin, China. Zhengye Biotechnology is led by Mr. Songlin Song and employs about 269 people. The company's shares have traded publicly since 2025.
At a market capitalization of $55.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001975641, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Zhengye Biotechnology do?
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Business description based on the company's public filings.
Company information
- Legal name
- Zhengye Biotechnology Holding Limited Class A
- Ticker
- NASDAQ: ZYBT
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Songlin Song
- Employees
- 269
- Headquarters
- No.1 Lianmeng Road, Jilin, China
- Phone
- 86 432 6304 7008
- Website
- jlzybio.com
- IPO year
- 2025
- Market cap
- $54.97M
- SEC CIK
- 0001975641
Companies similar to Zhengye Biotechnology
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TLPHTalphera Inc. | 1.08 | +2.86% | $56.06M | vs ZYBT |
| SCYXSCYNEXIS Inc. | 4.22 | -11.72% | $41.99M | vs ZYBT |
| CPHIChina Pharma Holdings Inc. | 0.96 | +12.94% | $41.30M | vs ZYBT |
| IXHLIncannex Healthcare Inc. | 3.20 | +0.63% | $40.14M | vs ZYBT |
| INCRIntercure Ltd. | 5.03 | -1.95% | $75.47M | vs ZYBT |
| RMTIRockwell Medical Inc. | 8.02 | -2.43% | $32.32M | vs ZYBT |
| SHPHShuttle Pharmaceuticals Holdings Inc. | 5.55 | +17.83% | $26.44M | vs ZYBT |
| OPTHOptimi Health Corp. | 4.09 | 0.00% | $23.39M | vs ZYBT |